| Name | Title | Contact Details |
|---|---|---|
Lisa Annunziata |
Director, Human Resources | Profile |
Stephane Lebeau |
VP, HR M&A and Organizational Effectiveness | Profile |
Jason Knoblauch |
Chief Financial Officer | Profile |
David Fusco |
Executive Vice President and Chief Human Capital Officer | Profile |
Airway Therapeutics has extensive expertise in protein development for applications in the lungs and pediatrics.
Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics.
Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. The company is advancing a broad, diversified pipeline of multiple, selective small molecule therapeutics for highly sought-after disease-causing target proteins in oncology and immunology. The company`s cutting-edge platform was spun out of the labs of Vividion`s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA.
Trellis Bioscience is a leader in identifying rare protective antibodies by screening human blood cells.
Kineta Pharmaceuticals is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.